Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173
J. Allergy Clin. Immunol., Volume 139, Issue 4, April 2017, Pages 1396-1399.e12 | http://dx.doi.org/10.1016/j.jaci.2016.10.030